Answer
In INAVO120, stomatitis was very common with Itovebi (inavolisib) plus palbociclib and fulvestrant, affecting 51.2% of patients overall, with Grade 3 events in 5.6% and no Grade 4 events.
Sources for this answer
- Itovebi 3 mg & 9mg film-coated tabletsRoche Products Limited · emc · SmPC §4.8 Undesirable effects · Version 3Document updated
Sources checked